4//SEC Filing
Lo Steven 4
Accession 0001209191-19-043050
CIK 0001401667other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 4:38 PM ET
Size
5.5 KB
Accession
0001209191-19-043050
Insider Transaction Report
Form 4
Lo Steven
Chief Commercial Officer
Transactions
- Sale
COMMON STOCK
2019-07-22$10.04/sh−1,852$18,600→ 19,557 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.04 to $10.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001501959
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 4:38 PM ET
- Size
- 5.5 KB